Recent studies indicate that TP53 is mutated in approximately 75% of MPNST [7], while deletions of the CDKN2A gene, which codes for p16INK4A and p19ARF, are found in about 50% of neoplasms [8]. The gene discussed is CDKN2A; the disease is neoplasm.